959 related articles for article (PubMed ID: 31543433)
21. Wharton's Jelly Mesenchymal Stromal Cells as a Feeder Layer for the Ex Vivo Expansion of Hematopoietic Stem and Progenitor Cells: a Review.
Lo Iacono M; Anzalone R; La Rocca G; Baiamonte E; Maggio A; Acuto S
Stem Cell Rev Rep; 2017 Feb; 13(1):35-49. PubMed ID: 27853939
[TBL] [Abstract][Full Text] [Related]
22. Human chorionic-plate-derived mesenchymal stem cells and Wharton's jelly-derived mesenchymal stem cells: a comparative analysis of their potential as placenta-derived stem cells.
Kim MJ; Shin KS; Jeon JH; Lee DR; Shim SH; Kim JK; Cha DH; Yoon TK; Kim GJ
Cell Tissue Res; 2011 Oct; 346(1):53-64. PubMed ID: 21987220
[TBL] [Abstract][Full Text] [Related]
23. A GMP-compliant manufacturing method for Wharton's jelly-derived mesenchymal stromal cells.
Chu W; Zhang F; Zeng X; He F; Shang G; Guo T; Wang Q; Wu J; Li T; Zhong ZZ; Liang X; Hu J; Liu M
Stem Cell Res Ther; 2024 May; 15(1):131. PubMed ID: 38702793
[TBL] [Abstract][Full Text] [Related]
24. Wharton's jelly-derived mesenchymal stem cells attenuate sepsis-induced organ injury partially via cholinergic anti-inflammatory pathway activation.
Capcha JMC; Rodrigues CE; Moreira RS; Silveira MD; Dourado P; Dos Santos F; Irigoyen MC; Jensen L; Garnica MR; Noronha IL; Andrade L; Gomes SA
Am J Physiol Regul Integr Comp Physiol; 2020 Jan; 318(1):R135-R147. PubMed ID: 31596111
[TBL] [Abstract][Full Text] [Related]
25. Human Wharton's Jelly-Derived Stem Cells Display Immunomodulatory Properties and Transiently Improve Rat Experimental Autoimmune Encephalomyelitis.
Donders R; Vanheusden M; Bogie JF; Ravanidis S; Thewissen K; Stinissen P; Gyselaers W; Hendriks JJ; Hellings N
Cell Transplant; 2015; 24(10):2077-98. PubMed ID: 25310756
[TBL] [Abstract][Full Text] [Related]
26. Wharton's Jelly Mesenchymal Stromal Cells Support the Expansion of Cord Blood-derived CD34
Lo Iacono M; Russo E; Anzalone R; Baiamonte E; Alberti G; Gerbino A; Maggio A; La Rocca G; Acuto S
Cell Transplant; 2018 Jan; 27(1):117-129. PubMed ID: 29562783
[TBL] [Abstract][Full Text] [Related]
27. Bone Marrow and Wharton's Jelly Mesenchymal Stromal Cells are Ineffective for Myocardial Repair in an Immunodeficient Rat Model of Chronic Ischemic Cardiomyopathy.
Tang XL; Nasr M; Zheng S; Zoubul T; Stephan JK; Uchida S; Singhal R; Khan A; Gumpert A; Bolli R; Wysoczynski M
Stem Cell Rev Rep; 2023 Oct; 19(7):2429-2446. PubMed ID: 37500831
[TBL] [Abstract][Full Text] [Related]
28. Improving stemness and functional features of mesenchymal stem cells from Wharton's jelly of a human umbilical cord by mimicking the native, low oxygen stem cell niche.
Obradovic H; Krstic J; Trivanovic D; Mojsilovic S; Okic I; Kukolj T; Ilic V; Jaukovic A; Terzic M; Bugarski D
Placenta; 2019 Jul; 82():25-34. PubMed ID: 31174623
[TBL] [Abstract][Full Text] [Related]
29. Positive selection of Wharton's jelly-derived CD105(+) cells by MACS technique and their subsequent cultivation under suspension culture condition: A simple, versatile culturing method to enhance the multipotentiality of mesenchymal stem cells.
Amiri F; Halabian R; Dehgan Harati M; Bahadori M; Mehdipour A; Mohammadi Roushandeh A; Habibi Roudkenar M
Hematology; 2015 May; 20(4):208-16. PubMed ID: 25116042
[TBL] [Abstract][Full Text] [Related]
30. An Injectable Hyaluronan-Methylcellulose (HAMC) Hydrogel Combined with Wharton's Jelly-Derived Mesenchymal Stromal Cells (WJ-MSCs) Promotes Degenerative Disc Repair.
Choi UY; Joshi HP; Payne S; Kim KT; Kyung JW; Choi H; Cooke MJ; Kwon SY; Roh EJ; Sohn S; Shoichet MS; Han I
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33036383
[TBL] [Abstract][Full Text] [Related]
31. Stage-specific embryonic antigen 4 in Wharton's jelly-derived mesenchymal stem cells is not a marker for proliferation and multipotency.
He H; Nagamura-Inoue T; Tsunoda H; Yuzawa M; Yamamoto Y; Yorozu P; Agata H; Tojo A
Tissue Eng Part A; 2014 Apr; 20(7-8):1314-24. PubMed ID: 24279891
[TBL] [Abstract][Full Text] [Related]
32. Wharton's Jelly Derived-Mesenchymal Stem Cells: Isolation and Characterization.
Ranjbaran H; Abediankenari S; Mohammadi M; Jafari N; Khalilian A; Rahmani Z; Momeninezhad Amiri M; Ebrahimi P
Acta Med Iran; 2018 Jan; 56(1):28-33. PubMed ID: 29436792
[TBL] [Abstract][Full Text] [Related]
33. Wharton's jelly mesenchymal stromal/stem cells derived under chemically defined animal product-free low oxygen conditions are rich in MSCA-1(+) subpopulation.
Devito L; Badraiq H; Galleu A; Taheem DK; Codognotto S; Siow R; Khalaf Y; Briley A; Shennan A; Poston L; McGrath J; Gentleman E; Dazzi F; Ilic D
Regen Med; 2014; 9(6):723-32. PubMed ID: 25431909
[TBL] [Abstract][Full Text] [Related]
34. A simple and serum-free protocol for cryopreservation of human umbilical cord as source of Wharton's jelly mesenchymal stem cells.
Roy S; Arora S; Kumari P; Ta M
Cryobiology; 2014 Jun; 68(3):467-72. PubMed ID: 24704519
[TBL] [Abstract][Full Text] [Related]
35. Molecular and Functional Verification of Wharton's Jelly Mesenchymal Stem Cells (WJ-MSCs) Pluripotency.
Musiał-Wysocka A; Kot M; Sułkowski M; Badyra B; Majka M
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013696
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of non-muscle myosin II leads to G0/G1 arrest of Wharton's jelly-derived mesenchymal stromal cells.
Sharma T; Kumari P; Pincha N; Mutukula N; Saha S; Jana SS; Ta M
Cytotherapy; 2014 May; 16(5):640-52. PubMed ID: 24210786
[TBL] [Abstract][Full Text] [Related]
37. Are serum-free and xeno-free culture conditions ideal for large scale clinical grade expansion of Wharton's jelly derived mesenchymal stem cells? A comparative study.
Swamynathan P; Venugopal P; Kannan S; Thej C; Kolkundar U; Bhagwat S; Ta M; Majumdar AS; Balasubramanian S
Stem Cell Res Ther; 2014 Jul; 5(4):88. PubMed ID: 25069491
[TBL] [Abstract][Full Text] [Related]
38. The Molecular Regulatory Mechanism in Multipotency and Differentiation of Wharton's Jelly Stem Cells.
Ma L; He X; Wu Q
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629090
[TBL] [Abstract][Full Text] [Related]
39. Pluripotent gene expression in mesenchymal stem cells from human umbilical cord Wharton's jelly and their differentiation potential to neural-like cells.
Tantrawatpan C; Manochantr S; Kheolamai P; U-Pratya Y; Supokawej A; Issaragrisil S
J Med Assoc Thai; 2013 Sep; 96(9):1208-17. PubMed ID: 24163998
[TBL] [Abstract][Full Text] [Related]
40. Bone marrow vs Wharton's jelly mesenchymal stem cells in experimental sepsis: a comparative study.
Laroye C; Boufenzer A; Jolly L; Cunat L; Alauzet C; Merlin JL; Yguel C; Bensoussan D; Reppel L; Gibot S
Stem Cell Res Ther; 2019 Jun; 10(1):192. PubMed ID: 31248453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]